News

  • 18 December 2017

    CRT and Celgene sign drug discovery collaboration

    Cancer Research UK’s subsidiary Cancer Research Technology (CRT) has signed a drug discovery collaboration with Celgene for the development and commercialisation of new anti-cancer treatments.

  • 15 December 2017

    M&As this week: Allergan, Philab Holdings

    Ireland-based pharmaceutical company Allergan, through its subsidiaries Allergan Sales and Celestial Merger Sub, has agreed to acquire US-based development-stage biopharmaceutical company Repros Therapeutics.